Testing effectiveness (Phase 2)Ended earlyNCT00490100
What this trial is testing
Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1
Who this might be right for
Growth FailureX-linked Severe Combined Immunodeficiency (XSCID)Growth Hormone Resistence
National Institute of Allergy and Infectious Diseases (NIAID) 6